Table of Contents Author Guidelines Submit a Manuscript
Advances in Pharmacological Sciences
Volume 2016, Article ID 3040724, 7 pages
http://dx.doi.org/10.1155/2016/3040724
Research Article

Pharmacological Evaluation of Naproxen Metal Complexes on Antinociceptive, Anxiolytic, CNS Depressant, and Hypoglycemic Properties

Department of Clinical Pharmacy & Pharmacology, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh

Received 7 April 2016; Accepted 17 May 2016

Academic Editor: Antonio Ferrer-Montiel

Copyright © 2016 Md. Sharif Hasan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. P. Kostova, I. I. Manolov, I. N. Nicolova, and N. D. Danchev, “New metal complexes of 4-methyl-7-hydroxycoumarin sodium salt and their pharmacological activity,” Il Farmaco, vol. 56, no. 9, pp. 707–713, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. I. Sheikhshoaie, A. Badiei, and M. Ghazizadeh, “Synthesis and spectroscopic studies of two new complexes containing Fe (III) and Mo (VI) of two tridentate ONO donor sets ligands,” Der Chemical Sinica, vol. 3, article 24, 2012. View at Google Scholar
  3. A. Sabastiyan and M. Y. Suvaikin, “Synthesis, characterization and antimicrobial activity of 2-(dimethylaminomethyl) isoindoline-1,3-dione and its cobalt(II) and nickel(II) complexes,” Advances in Applied Science Research, vol. 3, pp. 45–50, 2012. View at Google Scholar
  4. A. S. Munde, V. A. Shelke, S. M. Jadhav et al., “Synthesis, characterization and antimicrobial activities of some transition metal complexes of biologically active asymmetrical tetradentate ligands,” Advances in Applied Science Research, vol. 3, pp. 175–182, 2012. View at Google Scholar
  5. S. I. Habib, M. A. Baseer, and P. A. Kulkarni, “Synthesis and antimicrobial activity of Cobalt (II), Nickel (II), and Copper (II) complexes of some 2′-hydroxychalcones,” Der Chemica Sinica, vol. 2, pp. 27–32, 2011. View at Google Scholar
  6. S. Borhade, “Synthesis, characterisation and spectrophotometric determination of Fe (II) complex of 2,4-dihydroxybenzaldehyde isonicotinoyl hydrazone (E)-N'-(2,4- dihydroxybenzylidene) isonicotinohydrazide, it’s application & biological activity,” Der Chemica Sinica, vol. 2, no. 4, pp. 64–71, 2011. View at Google Scholar
  7. I. Kostova and G. Momekov, “New zirconium (IV) complexes of coumarins with cytotoxic activity,” European Journal of Medicinal Chemistry, vol. 41, no. 6, pp. 717–726, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. F. A. Adekunle, J. A. O. Woods, O. O. E. Onawumi, and O. A. Odunola, “Synthesis and characterization of nickel(II) complexes of various substituted acid hydrazides,” Asian Journal of Chemistry, vol. 22, no. 7, pp. 5543–5550, 2010. View at Google Scholar · View at Scopus
  9. M. Q. Zhang, Y. C. Zhu, J. G. Wu, P. Shi, R. W. Deng, and Z. N. Chen, “Some transition metal complexes with naproxen,” Chemical Papers, vol. 55, no. 3, pp. 202–205, 2001. View at Google Scholar · View at Scopus
  10. M. S. Hasan, R. Kayesh, F. Begum, and S. M. Rahman, “Transition metal complexes of naproxen: synthesis, characterization, forced degradation studies, and analytical method verification,” Journal of Analytical Methods in Chemistry, vol. 2016, Article ID 3560695, 10 pages, 2016. View at Publisher · View at Google Scholar
  11. H. Hemayet, I. A. Jahan, H. S. Islam, D. S. Kanti, H. Arpona, and A. Arif, “Phytochemical screening and anti-nociceptive properties of the ethanolic leaf extract of tremaCannabina lour,” Advanced Pharmaceutical Bulletin, vol. 3, no. 1, pp. 103–108, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Goshwami, M. M. Rahman, M. A. Muhit, and M. S. Islam, “Antinociceptive activity of leaves of Lasia spinosa,” Archives of Applied Science Research, vol. 4, pp. 2431–2434, 2012. View at Google Scholar
  13. N. Das, D. Goshwami, M. S. Hasan, Z. A. Mahmud, S. Z. Raihan, and M. Z. Sultan, “Evaluation of antinociceptive, anti-inflammatory and anxiolytic activities of methanolic extract of Terminalia citrina leaves,” Asian Pacific Journal of Tropical Disease, vol. 5, supplement 1, pp. S137–S141, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. E. M. Williamson, D. T. Okpako, and F. J. Evans, “Selection, preparation and pharmacological evaluation of plant material,” in Pharmacological Methods in Phytotherapy Research, vol. 1, p. 184, John Wiley & Sons, New York, NY, USA, 1st edition, 1996. View at Google Scholar
  15. S. Shahreen, J. Banik, A. Hafiz et al., “Antihyperglycemic activities of leaves of three edible fruit plants (Averrhoa carambola, Ficus hispida and Syzygium samarangense) of Bangladesh,” African Journal of Traditional, Complementary, and Alternative Medicines, vol. 9, no. 2, pp. 287–291, 2012. View at Google Scholar · View at Scopus
  16. A. Ganguly, Z. Al Mahmud, S. Kumar Saha, and S. M. Abdur Rahman, “Evaluation of antinociceptive and antidiarrhoeal properties of Manilkara zapota leaves in Swiss albino mice,” Pharmaceutical Biology, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Le Bars, M. Gozariu, and S. W. Cadden, “Animal models of nociception,” Pharmacological Reviews, vol. 53, no. 4, pp. 597–652, 2001. View at Google Scholar · View at Scopus
  18. M. C. Mohanta, A. Ganguly, F. Begum, and S. M. A. Rahman, “Evaluation of anti-nociception properties of Drynaria quercifolia rhizome in Swiss-albino mice,” Journal of Pharmacy Research, vol. 8, pp. 41–44, 2013. View at Google Scholar
  19. P. Tiwari, R. Verma, D. Ahirwar, A. Chandy, and S. Dwivedi, “Evaluation of anxiolytic effect of Syzygium aromaticum: a traditional herb of India,” Asian Pacific Journal of Tropical Disease, vol. 4, supplement 1, pp. S77–S80, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Dhir, S. S. V. Padi, P. S. Naidu, and S. K. Kulkarni, “Protective effect of naproxen (non-selective COX-inhibitor) or rofecoxib (selective COX-2 inhibitor) on immobilization stress-induced behavioral and biochemical alterations in mice,” European Journal of Pharmacology, vol. 535, no. 1–3, pp. 192–198, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. C. A. Rouzer, “A new Class of Cyclooxygenase Inhibitors with Anti-Anxiety Activit,” VICB Commun. 7, 2013, http://www.vanderbilt.edu/vicb/DiscoveriesArchives/cox-2_anti-anxiety.html.
  22. A. Takeda, M. Hirate, H. Tamano, and N. Oku, “Release of glutamate and GABA in the hippocampus under zinc deficiency,” Journal of Neuroscience Research, vol. 72, no. 4, pp. 537–542, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. A. J. Russo, “Decreased zinc and increased copper in individuals with anxiety,” Nutrition and Metabolic Insights, vol. 4, pp. 1–5, 2011. View at Google Scholar
  24. J. R. J. Sorenson, L. S. F. Soderberg, M. V. Chidambaram et al., “Bioavailable copper complexes offer a physiologic approach to treatment of chronic diseases,” Advances in Experimental Medicine and Biology, vol. 258, pp. 229–234, 1989. View at Google Scholar · View at Scopus
  25. C. V. Jose and T. J. Anto, “Characterization and CNS depressant studies on complexes of Mn(II), Co(II) and Ni(II) with 2-(thiophene-2-formylimino)benzimidazole,” Asian Journal of Chemistry, vol. 22, no. 4, pp. 2495–2500, 2010. View at Google Scholar · View at Scopus
  26. B. Bannwarth, P. Netter, J. Pourel, R. J. Royer, and A. Gaucher, “Clinical pharmacokinetics of nonsteroidal anti-inflammatory drugs in the cerebrospinal fluid,” Biomedicine and Pharmacotherapy, vol. 43, no. 2, pp. 121–126, 1989. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Lerma and R. Martín del Río, “Chloride transport blockers prevent N-methyl-D-aspartate receptor-channel complex activation,” Molecular Pharmacology, vol. 41, no. 2, pp. 217–222, 1992. View at Google Scholar · View at Scopus
  28. T. Shaw, R. J. Lee, and L. D. Partridge, “Action of diphenylamine carboxylate derivatives, a family of non-steroidal anti-inflammatory drugs, on Ca2+i and Ca2+-activated channels in neurons,” Neuroscience Letters, vol. 190, no. 2, pp. 121–124, 1995. View at Publisher · View at Google Scholar · View at Scopus
  29. M. M. White and M. Aylwin, “Niflumic and flufenamic acids are potent reversible blockers of Ca2(+)-activated Cl- channels in Xenopus oocytes,” Molecular Pharmacology, vol. 37, no. 5, pp. 720–724, 1990. View at Google Scholar
  30. N. A. McCarty, S. McDonough, B. N. Cohen, J. R. Riordan, N. Davidson, and H. A. Lester, “Voltage-dependent block of the cystic fibrosis transmembrane conductance regulator C1 channel by two closely related arylaminobenzoates,” The Journal of General Physiology, vol. 102, pp. 1–23, 1993. View at Google Scholar
  31. R. M. Woodward, L. Polenzani, and R. Miledi, “Effects of fenamates and other nonsteroidal anti-inflammatory drugs on rat brain GABAA receptors expressed in Xenopus oocytes,” Journal of Pharmacology and Experimental Therapeutics, vol. 268, no. 2, pp. 806–817, 1994. View at Google Scholar · View at Scopus
  32. R. F. Halliwel, P. G. Davey, and J. J. Lambert, “A patch clamp study of the effects of ciprofloxacin and biphenyl acetic acid on rat hippocampal neurone GABAA and lonotropic glutamate receptors,” Neuropharmacology, vol. 34, no. 12, pp. 1615–1624, 1995. View at Publisher · View at Google Scholar · View at Scopus
  33. N. P. Franks and W. R. Lieb, “Molecular and cellular mechanisms of general anaesthesia,” Nature, vol. 367, no. 6464, pp. 607–614, 1994. View at Publisher · View at Google Scholar · View at Scopus
  34. D. R. Curtis and G. A. R. Johnston, “Convulsant alkaloids,” in Neuropoisons, Their Pathophysiological Actions, L. L. Simpson and D. R. Curtis, Eds., vol. 2 of Poisons of Plant Origin, pp. p207–248, Plenum Press, New York, NY, USA, 1994. View at Google Scholar
  35. M. M. Savić, S. Huang, R. Furtmüller et al., “Are GABAA receptors containing α5 subunits contributing to the sedative properties of benzodiazepine site agonists?” Neuropsychopharmacology, vol. 33, no. 2, pp. 332–339, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Sitasawad, M. Deshpande, M. Katdare, S. Tirth, and P. Parab, “Beneficial effect of supplementation with copper sulfate on STZ-diabetic mice (IDDM),” Diabetes Research and Clinical Practice, vol. 52, no. 2, pp. 77–84, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. P. L. Walter, A. Kampkötter, A. Eckers et al., “Modulation of FoxO signaling in human hepatoma cells by exposure to copper or zinc ions,” Archives of Biochemistry and Biophysics, vol. 454, no. 2, pp. 107–113, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Ybarra, A. Behrooz, A. Gabriel, M. H. Koseoglu, and F. Ismail-Beigi, “Glycemia-lowering effect of cobalt chloride in the diabetic rat: increased GLUT1 mRNA expression,” Molecular and Cellular Endocrinology, vol. 133, no. 2, pp. 151–160, 1997. View at Publisher · View at Google Scholar · View at Scopus
  39. J. M. May and C. S. Contoreggi, “The mechanism of the insulin-like effects of ionic zinc,” The Journal of Biological Chemistry, vol. 257, no. 8, pp. 4362–4368, 1982. View at Google Scholar · View at Scopus
  40. G. Boden, “Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes,” Experimental and Clinical Endocrinology and Diabetes, vol. 111, no. 3, pp. 121–124, 2003. View at Publisher · View at Google Scholar · View at Scopus